Please download the PDF here and read it!

As part of its growing commitment to the Asian market, IBSA will participate once again in CPhI Japan 2025, a major international event for the pharmaceutical industry in the APAC region. With more than 20,000 attendees and representatives from over 50 countries expected, this prestigious exhibition provides an essential platform for IBSA to strengthen its position in the region and highlight its innovative solutions tailored to meet the diverse needs of patients and healthcare professionals worldwide.

“Japan and the broader Asia-Pacific region represent significant growth opportunities for IBSA,” says Andrea Taborelli, Senior Business Development and Licensing Manager. “CPhI Japan is the perfect stage for us to engage with key players in the industry, includi ... ...